157 related articles for article (PubMed ID: 31954541)
21. Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®).
Acosta FJ; Ramallo-Fariña Y; Bosch E; Mayans T; Rodríguez CJ; Caravaca A
Schizophr Res; 2013 May; 146(1-3):196-200. PubMed ID: 23474024
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia.
Velligan D; Mintz J; Maples N; Xueying L; Gajewski S; Carr H; Sierra C
Schizophr Bull; 2013 Sep; 39(5):999-1007. PubMed ID: 23086987
[TBL] [Abstract][Full Text] [Related]
23. A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study.
Hale TM; Jethwani K; Kandola MS; Saldana F; Kvedar JC
J Med Internet Res; 2016 Apr; 18(5):e91. PubMed ID: 27154462
[TBL] [Abstract][Full Text] [Related]
24. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
25. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
26. Monitoring treatment and managing adherence in schizophrenia.
Marder SR
J Clin Psychiatry; 2013 Oct; 74(10):e21. PubMed ID: 24229761
[TBL] [Abstract][Full Text] [Related]
27. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
Hegedüs A; Kozel B
Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
[TBL] [Abstract][Full Text] [Related]
28. Improving treatment adherence in patients with schizophrenia.
Kane JM
J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
30. Medication Adherence Decisions in Patients With Schizophrenia.
Kikkert MJ; Dekker J
Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
[TBL] [Abstract][Full Text] [Related]
31. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
[TBL] [Abstract][Full Text] [Related]
32. Pilot feasibility study of Heart2HAART: a smartphone application to assist with adherence among substance users living with HIV.
Himelhoch S; Kreyenbuhl J; Palmer-Bacon J; Chu M; Brown C; Potts W
AIDS Care; 2017 Jul; 29(7):898-904. PubMed ID: 28043176
[TBL] [Abstract][Full Text] [Related]
33. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.
Novick D; Montgomery W; Treuer T; Aguado J; Kraemer S; Haro JM
BMC Psychiatry; 2015 Aug; 15():189. PubMed ID: 26239486
[TBL] [Abstract][Full Text] [Related]
34. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
35. Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.
Kretchy IA; Osafo J; Agyemang SA; Appiah B; Nonvignon J
Psychiatry Res; 2018 Jan; 259():289-294. PubMed ID: 29091831
[TBL] [Abstract][Full Text] [Related]
36. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
[TBL] [Abstract][Full Text] [Related]
37. Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder.
Dunn KE; King VL; Brooner RK
Drug Alcohol Depend; 2016 Mar; 160():212-7. PubMed ID: 26851987
[TBL] [Abstract][Full Text] [Related]
38. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
39. Pilot Study to Test the Effectiveness of Different Financial Incentives to Improve Medication Adherence.
Garza KB; Owensby JK; Braxton Lloyd K; Wood EA; Hansen RA
Ann Pharmacother; 2016 Jan; 50(1):32-8. PubMed ID: 26447193
[TBL] [Abstract][Full Text] [Related]
40. Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study.
Gutiérrez-Casares JR; Cañas F; Rodríguez-Morales A; Hidalgo-Borrajo R; Alonso-Escolano D
CNS Spectr; 2010 May; 15(5):327-37. PubMed ID: 20448523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
